Exciting Progress: A Promising Life-Extension Drug for Large Breeds of Dogs is Nearing Completion
Loyal conducted early studies by dosing 130 research dogs with its experimental drug, demonstrating the ability to reduce IGF-1 levels in large dogs to those found in medium-size dogs. Minor side effects such as temporary loose stools were reported in two dogs, but no major side effects have been observed, according to Halioua. To evaluate …